Navigation Links
Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting
Date:5/7/2009

be presented at the 2009 APS meeting:

Thursday, May 7: 4:15-5:45 PM

Poster 301: Efficacy and Safety of Tapentadol ER for Chronic Low Back Pain: Results of a Randomized, Double-blind, Placebo- and Active-controlled Phase 3 Study; Primary investigator: Robert Buynak, M.D.

Poster 293: Efficacy, Safety, and Gastrointestinal Tolerability of Tapentadol ER in a Randomized, Double-blind, Placebo- and Active-controlled Phase III Study of Patients With Chronic Low Back Pain; Primary investigator: Robert Buynak, M.D.

Friday, May 8: 4:00-5:30 PM

Poster 306: A Randomized, Double-blind, Placebo- and Active-controlled Phase 3 Study of Tapentadol ER for Chronic Low Back Pain: Analysis of Efficacy Endpoint Sensitivity; Primary investigator: Mila Etropolski, M.D.

J&JPRD and Ortho-McNeil-Janssen Pharmaceuticals, Inc. are wholly owned subsidiaries of Johnson & Johnson.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) is a wholly owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com/.

PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

PriCara(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a major health care company in the United States dedicated to the needs of primary car
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
2. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
3. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
4. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
5. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
6. Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL
7. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
8. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
9. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
10. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 2015 La solución de ... cuidado al paciente a lo ... Royal Philips  (NYSE: PHG, AEX: PHIA) ... Cardiovascular , un sistema web de gestión de imágenes ... y compartir imágenes cardiovasculares e información en cualquier momento, ...
(Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "12th ... and Production" report to their offering. ... of Biopharmaceutical Manufacturing Capacity and Production is the ... manufacturing organizations, current and projected future capacity and ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... KINNELON, N.J., Sept. 8, 2011 Life Recovery Systems ... three-year agreement by Premier Purchasing Partners, LP, the group ... the ThermoSuit System available by contract to its more ... award, LRS,s first GPO contract, Robert Neary, LRS Director ...
... Elusys Therapeutics, Inc. (Elusys), a  biopharmaceutical company developing ... awarded the first U.S. Government contract to develop ... use via intramuscular injection (IM). The five year ... multiple animal efficacy studies as well as human ...
Cached Medicine Technology:Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 2Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management 3Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 2Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection 3
(Date:8/30/2015)... , ... August 31, 2015 , ... Negotiating an FDA ... 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/importholdcrisis , US authorities are holding ... products, and imports from India. , With alerts on an uptick and a new ...
(Date:8/30/2015)... ... 2015 , ... ChopChop Kids, the nonprofit publisher of the ... two new officers to serve on the organization’s Board of Directors in accordance ... kids to cook real food with their families and help continue to drive ...
(Date:8/30/2015)... ... August 30, 2015 , ... The law firm of ... Kotin was recently elected to membership in the American Board of Trial Advocates ... recognition and outstanding professionalism. , ABOTA is an invitation-only, national organization comprised ...
(Date:8/30/2015)... ... ... Lizzie’s Lice Pickers , a company that offers professional live removal service, ... head checks for just $10, which is a significant discount from the normal price ... treatment products. “With kids returning to school, it is very important to be on ...
(Date:8/30/2015)... , ... August 30, 2015 , ... ... joined the company as the new Global Communications Director for InHealth Media. ... experience having spent the last 16 years doing on-air television, producing shows, on ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 2Health News:FDAnews Announces — Negotiating an FDA Import Hold Crisis: Strategies for Challenging FDA Findings Webinar, Sept. 22, 2015 3Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:InHealth Media Appoints New Global Communications Director 2
... DALLAS, Dec. 17 The following feature is by Devon ... , People often assume they have little control over how ... be scheduled, doctors prescribe treatments and employers provide health coverage to ... ways to trim your health costs and still get the care ...
... , DAYTON, Ohio, Dec. 17 Good ... pelvic health issues with the launch of the Good Samaritan Hospital ... designed to help treat two common medical problems - lack of ... rectum (pelvic organ prolapse). Three out of four women report some ...
... WASHINGTON, Dec. 17 The National Council on Disability ... Houston, 5150 Westheimer, Houston, TX, beginning at 8:30 a.m. on Tuesday, ... 21, 2010. This meeting is open to the public. , ... country on what works and what does not for people with ...
... study show that Chinese research output has increased from just ... Faculty of 1000, which selects only the top ... papers from Chinese universities and institutes since 2001. While only ... over fourfold in 2008 and is set to be even ...
... Jay and Maureen Neitz, the husband-and-wife team whose pioneering research ... vision disorders, as the inaugural recipients of the Jay Pepose ... by a $1 million endowment established this year through a ... Feigenbaum ,74, his wife. The endowment primarily supports graduate research ...
... ... resilient, ‘two-in-one’ foam roller. This patented foam roller has one side that is flatter ... rollers available. , ... Minneapolis, MN (PRWEB) December 17, 2009 -- The SMARTROLLER® from OPTP is ...
Cached Medicine News:Health News:Six Ways to Slash Your Health Costs 2Health News:Six Ways to Slash Your Health Costs 3Health News:Six Ways to Slash Your Health Costs 4Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2Health News:China rapidly catching up in research impact 2Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:OPTP Introduces the SMARTROLLER 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: